National Live Broadcast Grand Rounds

CITY OF HOPE: State of the Art of Cancer Therapeutics: Focus on the Impact of Immunology Across Tumor Types

Activity Information:
Day: Tuesday, February 19, 2019 
Time: 12:00 pm-1:00 pm PST
AMA PRA Category 1 Credit™ Issued: 1.0
Sumanta Kumar Pal, MD
Associate Clinical Professor
Department of Medical Oncology & Therapeutics Research
City of Hope
Duarte, CA
• Describe the core science behind and implications of immuno-oncology as it relates to key biomarkers and pathways
• Discuss how the science of immuno-oncology affects treatment across tumor types, including emerging biomarkers and treatment options.
Educational Format: 
This activity will be didactic with a Q&A period. This activity will be evaluated by each participant at the conclusion of the lecture.

Target Audience: 
The activity content is oriented to address the educational needs of community and institution-based medical oncologists, hematologists, surgical oncologists, interventional radiologists, pathologists, PAs, nurse practitioners, oncology nurses, pharmacists, and other healthcare providers involved in the management of patients with cancer.
Provider Statement: 
This activity is provided by City of Hope in collaboration with Paradigm Medical Communications, LLC, as an educational partner.
Accreditation Statement:
City of Hope is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation:
City of Hope designates this live activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
PA Continuing Education:
PAs may claim a maximum of 1.0 Category 1 credit for completing this activity. NCCPA accepts AMA PRA Category 1 CreditTM from organizations accredited by ACCME or a recognized state medical society.
Nurse Practitioner Continuing Education:
The American Academy of Nurse Practitioners Certification Program (AANPCP) accepts certificates of participation for educational activities certified for AMA PRA Category 1 CreditTM from organizations accredited by the ACCME. Individuals are responsible for checking with the AANPCP for further guidelines.
Allied Health Care Professionals:
Registered nurses may report up to 1.0 credit hour toward the continuing education requirement for license renewal by their state Board of Registered Nurses (BRN). AMA PRA Category 1 CreditTM may be noted on the license renewal application in lieu of a BRN provider number. The National Commission on Certification of Physician Assistants states that AMA PRA Category 1 CreditTM accredited courses are acceptable for continuing medical education requirements for recertification. 

To receive a CME certificate of participation for this activity, participants must:
• Create an individual registration profile
• Sign in to the Zoom link using your Full Name and email as it appears on your registration
• View the webcast in its entirety
• After the meeting you will also receive an email with instructions to log in, complete, and submit your online evaluation and posttest

 A certificate of participation will be available for download/printing immediately following your successful completion of the posttest and evaluation
For questions regarding CME credit, contact the Paradigm CME Department at (845) 398-5949.

This activity is supported by educational grants from AbbVie, Inc.; Genentech, Inc.; Merck & Co., Inc.; Pharmacyclics, Inc.; and Takeda Oncology.
As an organization accredited by the ACCME, City of Hope requires everyone who is in a position to control the content of an education activity to disclose prior to the activity all relevant financial relationships with any commercial interest. All disclosed relevant financial relationships will have been resolved prior to the commencement of the activity. We further require that prior to the activity faculty/presenters have disclosed their intention to discuss any off-label and/or investigational (not yet approved for any purpose) use of pharmaceuticals or medical devices. 
Moderator/Presenter: Dr. Sumanta Kumar Pal has indicated that he is a Consultant for Astellas Pharma US, Inc.; AVEO Pharmaceuticals, Inc.; Bristol-Myers Squibb Company; Eisai, Inc.; Exelixis, Inc.; Genentech, Inc.; Ipsen Pharma; Novartis; Pfizer Inc.; and Roche. Reviewer/Steering Committee: Dr. Daneng Li has indicated that he does not have any relevant disclosures.

Paradigm Medical Communications, LLC, staff members have no financial relationships to disclose.
To register for this complimentary meeting, please click Continue below or call toll-free: (877) 252-5100, ext. 1.